Quest Diagnostics is partnering with Google Cloud to enhance Quest's data management, refine data analytics, and provide personalized experiences to patients, providers, and other customers. The venture marks one of the first times a national laboratory provider has employed these technologies across various operations and administrative areas such as R&D, customer experience, and operations. All these while ensuring data privacy and security.
The recall involves removing Pipeline Vantage 027 device models from use and sale and updating instructions for Pipeline vantage 021 models. Medtronic’s Pipeline Vantage embolization devices with Shield Technology treat bulges in the artery walls (aneurysms) of the brain. The endovascular devices go into blood vessels through a small catheter to the aneurysm location. There, a small, braided tube blocks off blood flow to the bulging area.
Google on Tuesday announced health-care updates to Search, including a way for people with specific health conditions to compare their experiences with others. The company unveiled a new feature called "What People Suggest," which uses AI to pull together online commentary from patients with similar diagnoses. A patient with arthritis would be able to look up how other people with the condition approach exercise, for instance. The feature is available on mobile devices in the U.S., Google said.
The Department of Veterans Affairs plans to bring its new Federal Electronic Health Records system to nine more medical centers in 2026 than previously announced. The program, which has suffered multiple setbacks since it was first introduced in the Pacific Northwest in late 2020, was to restart at four sites in Michigan in 2026. However, following meetings between the VA, medical center personnel and Oracle Health, the company that designed the system, more sites will be added in locations that will be determined following an in-depth analysis.
On Tuesday, a group of senators sent letters to five telehealth companies that offer care through direct-to-consumer portals from pharmaceutical manufacturers Pfizer and Eli Lilly, interrogating their financial relationships. The questions seek to determine whether contracts between pharma and telehealth companies could violate the federal anti-kickback statute.